Albert Yeung

All filings by Albert Yeung on record concern China Biologic Products, Inc. In total, 7 filings cover trades dated from 31 August 2012 to 9 December 2016.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 12 December 2016 came the latest disclosure, an option exercise for €199k in China Biologic Products, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.